Metropolitan Life Insurance CO Neurocrine Biosciences Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

47 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$72.45 - $94.81 $1.54 Million - $2.02 Million	-21,304 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$79.65 - $106.22 $1.7 Million - $2.26 Million	21,304 New	21,304 $1.81 Million
Q4 2021 Mar 30, 2023	SELL	$79.65 - $106.22 $29,072 - $38,770	-365 Reduced 1.68%	21,304 $1.81 Million
Q4 2021 Feb 15, 2022	SELL	$79.65 - $106.22 $29,072 - $38,770	-365 Reduced 1.68%	21,304 $1.81 Million
Q3 2021 Jun 21, 2023	BUY	$86.18 - $99.03 $1.87 Million - $2.15 Million	21,669 New	21,669 $2.08 Million
Q3 2021 Mar 30, 2023	SELL	$86.18 - $99.03 $61,877 - $71,103	-718 Reduced 3.21%	21,669 $2.08 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $61,877 - $71,103	-718 Reduced 3.21%	21,669 $2.08 Million
Q2 2021 Jun 21, 2023	BUY	$89.43 - $102.27 $2 Million - $2.29 Million	22,387 New	22,387 $2.18 Million
Q2 2021 Mar 30, 2023	SELL	$89.43 - $102.27 $21,463 - $24,544	-240 Reduced 1.06%	22,387 $2.18 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $2 Million - $2.29 Million	22,364 Added 97234.78%	22,387 $2.18 Million
Q1 2021 Jun 26, 2023	BUY	$87.57 - $119.4 $1.98 Million - $2.7 Million	22,627 New	22,627 $2.2 Billion
Q1 2021 Mar 30, 2023	BUY	$87.57 - $119.4 $1.37 Million - $1.87 Million	15,640 Added 223.84%	22,627 $2.2 Million
Q1 2021 May 14, 2021	SELL	$87.57 - $119.4 $609,837 - $831,501	-6,964 Reduced 99.67%	23 $2.2 Million
Q4 2020 Jun 22, 2023	BUY	$86.91 - $108.33 $607,240 - $756,901	6,987 New	6,987 $669,000
Q4 2020 Mar 30, 2023	SELL	$86.91 - $108.33 $11,819 - $14,732	-136 Reduced 1.91%	6,987 $669,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $11,819 - $14,732	-136 Reduced 1.91%	6,987 $670,000
Q3 2020 Jun 26, 2023	BUY	$96.16 - $135.15 $684,947 - $962,673	7,123 New	7,123 $684,000
Q3 2020 Mar 30, 2023	SELL	$96.16 - $135.15 $17,789 - $25,002	-185 Reduced 2.53%	7,123 $684,000
Q3 2020 Nov 13, 2020	SELL	$96.16 - $135.15 $17,789 - $25,002	-185 Reduced 2.53%	7,123 $685,000
Q2 2020 Jun 26, 2023	BUY	$85.09 - $130.36 $621,837 - $952,670	7,308 New	7,308 $891,000
Q2 2020 Mar 30, 2023	BUY	$85.09 - $130.36 $76,751 - $117,584	902 Added 14.08%	7,308 $891,000
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $76,751 - $117,584	902 Added 14.08%	7,308 $892,000
Q1 2020 Jul 12, 2023	BUY	$75.11 - $113.76 $481,154 - $728,746	6,406 New	6,406 $554,000
Q1 2020 Mar 30, 2023	SELL	$75.11 - $113.76 $9,764 - $14,788	-130 Reduced 1.99%	6,406 $554,000
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $9,764 - $14,788	-130 Reduced 1.99%	6,406 $554,000
Q4 2019 Jul 12, 2023	BUY	$86.8 - $118.57 $567,324 - $774,973	6,536 New	6,536 $702,000
Q4 2019 Mar 30, 2023	SELL	$86.8 - $118.57 $10,589 - $14,465	-122 Reduced 1.83%	6,536 $702,000
Q4 2019 Feb 14, 2020	SELL	$86.8 - $118.57 $10,589 - $14,465	-122 Reduced 1.83%	6,536 $703,000
Q3 2019 Jul 12, 2023	BUY	$83.82 - $101.5 $558,073 - $675,787	6,658 New	6,658 $599,000
Q3 2019 Mar 30, 2023	BUY	$83.82 - $101.5 $2,011 - $2,436	24 Added 0.36%	6,658 $599,000
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $2,011 - $2,436	24 Added 0.36%	6,658 $600,000
Q2 2019 Jul 12, 2023	BUY	$72.24 - $91.27 $479,240 - $605,485	6,634 New	6,634 $560,000
Q2 2019 Mar 30, 2023	SELL	$72.24 - $91.27 $11,052 - $13,964	-153 Reduced 2.25%	6,634 $560,000
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $11,052 - $13,964	-153 Reduced 2.25%	6,634 $560,000
Q1 2019 Jul 13, 2023	BUY	$69.31 - $91.53 $470,406 - $621,214	6,787 New	6,787 $597,000
Q1 2019 Mar 30, 2023	BUY	$69.31 - $91.53 $470,406 - $621,214	6,787 New	6,787 $597,000
Q1 2019 May 16, 2019	SELL	$69.31 - $91.53 $390,769 - $516,046	-5,638 Reduced 45.38%	6,787 $597,000
Q1 2019 May 15, 2019	BUY	$69.31 - $91.53 $385,779 - $509,455	5,566 Added 81.15%	12,425 $435,000
Q4 2018 Jul 13, 2023	BUY	$68.32 - $124.36 $468,606 - $852,985	6,859 New	6,859 $489,000
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $1,503 - $2,735	-22 Reduced 0.32%	6,859 $490,000
Q3 2018 Jul 13, 2023	BUY	$98.88 - $125.85 $680,393 - $865,973	6,881 New	6,881 $846 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $13,546 - $17,241	-137 Reduced 1.95%	6,881 $846,000
Q2 2018 Aug 15, 2018	BUY	$75.3 - $105.99 $30,120 - $42,396	400 Added 6.04%	7,018 $0
Q1 2018 May 15, 2018	BUY	$75.88 - $92.43 $6,905 - $8,411	91 Added 1.39%	6,618 $0
Q4 2017 Feb 15, 2018	SELL	$58.53 - $77.59 $3,570 - $4,732	-61 Reduced 0.93%	6,527 $506,000
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $16,117 - $20,590	336 Added 5.37%	6,588 $404,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,252	6,252 $288,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.78 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.26 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$647 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$323 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$234 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account